BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced the U.S. Food and Drug Administration (FDA) ...

Glucocorticoids (GCs) are widely used medications to treat inflammation caused by conditions like arthritis, asthma, ...

Doctors say there are easy, inexpensive (or free!) arthritis self-care remedies that can make a world of difference. Odds are ...

Zura Bio has initiated the Phase II TibuSURE trial to assess tibulizumab, in treating systemic sclerosis (SSc) in adult patients.

The immune system is our unsung hero when it comes to staying healthy and sickness-free. Without us noticing, it mounts round ...

The team delves into applications like cancer immunotherapy, where NIR-II PAI can help monitor the response to treatment, ...

“It is clear that NETs contribute to DED and this licensing agreement represents an important step in bringing our innovative treatments to patients who live with the daily challenges of DED,” said ...

Bristol Myers on Monday said the two Phase 3 studies met their primary endpoint, with a significantly greater proportion of Sotyktu-treated patients achieving at least a 20% improvement in signs and ...

Cellular research indicates that neuropilin-1 plays a crucial role in pain signaling, presenting a potential pathway for ...

Researchers from Nanjing University and Peking University presented the discovery and preclinical characterization of novel NLRP3 inhibitors as potential therapeutic candidates for the treatment of ...

A research team from the University of Central Florida's College of Medicine conducted a study of patient perceptions of ...

The management of rheumatoid arthritis has seen tremendous changes over the past 25 years, since the increasing availability of biological disease-modifying antirheumatic drugs (DMARDs) with various ...